Research Peptide Comparison
Retatrutide Pen 20mg and Tirzepatide 15mg are both GLP-1 Peptides research peptides available from Neovia Peptides. This comparison highlights the key differences in specifications, pricing, and availability to help inform your research decisions.
Retatrutide is a synthetic triple agonist of the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP) and glucagon receptors. The simultaneous activation of all three incretin/glucagon pathways places it at the leading edge of metabolic research.
Compared to Tirzepatide 15mg, Retatrutide Pen 20mg is priced at £150.00 with 99%+ verified purity. Its CAS registry number is 2381089-83-2. It has a molecular weight of 4875.42 g/mol.
Retatrutide Pen 20mg is available in 20mg, 40mg and ships with a full Certificate of Analysis from Janoshik Analytical. It is priced £96.01 higher than Tirzepatide 15mg.
Tirzepatide is a 39-amino-acid synthetic peptide that functions as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. By engaging both incretin pathways simultaneously, it has been investigated for its effects on insulin secretion, glucagon suppression, gastric emptying and energy homeostasis, and is one of the most-studied dual incretin agonists in modern metabolic research.
Compared to Retatrutide Pen 20mg, Tirzepatide 15mg is priced at £53.99 with 99.5%+ verified purity. Its CAS registry number is 2023788-19-2. It has a molecular weight of 4813.52 g/mol.
Tirzepatide 15mg is available in 15mg, 30mg, 60mg and ships with a full Certificate of Analysis from Janoshik Analytical. At £96.01 less than Retatrutide Pen 20mg, it is the more affordable option in this comparison.
All products sold by Neovia Peptides are strictly for in-vitro research and laboratory use only. Not intended for human or veterinary use, food additives, drugs, or cosmetics. By purchasing from this website, you agree that you understand and accept these terms.
